These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7504020)

  • 1. Protective effects of selectin chimeras in neutrophil-mediated lung injury.
    Mulligan MS; Watson SR; Fennie C; Ward PA
    J Immunol; 1993 Dec; 151(11):6410-7. PubMed ID: 7504020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for L-selectin in neutrophil-mediated lung injury in rats.
    Mulligan MS; Miyasaka M; Tamatani T; Jones ML; Ward PA
    J Immunol; 1994 Jan; 152(2):832-40. PubMed ID: 7506737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody.
    Mulligan MS; Jones ML; Bolanowski MA; Baganoff MP; Deppeler CL; Meyers DM; Ryan US; Ward PA
    J Immunol; 1993 Jun; 150(12):5585-95. PubMed ID: 8390538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140).
    Mulligan MS; Polley MJ; Bayer RJ; Nunn MF; Paulson JC; Ward PA
    J Clin Invest; 1992 Oct; 90(4):1600-7. PubMed ID: 1383277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    Mulligan MS; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of leukocyte adhesion molecules in complement-induced lung injury.
    Mulligan MS; Smith CW; Anderson DC; Todd RF; Miyasaka M; Tamatani T; Issekutz TB; Ward PA
    J Immunol; 1993 Mar; 150(6):2401-6. PubMed ID: 8095513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement and role of C5a in acute lung inflammatory injury in rats.
    Mulligan MS; Schmid E; Beck-Schimmer B; Till GO; Friedl HP; Brauer RB; Hugli TE; Miyasaka M; Warner RL; Johnson KJ; Ward PA
    J Clin Invest; 1996 Jul; 98(2):503-12. PubMed ID: 8755663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of oligosaccharides in P-selectin-dependent lung injury.
    Mulligan MS; Paulson JC; De Frees S; Zheng ZL; Lowe JB; Ward PA
    Nature; 1993 Jul; 364(6433):149-51. PubMed ID: 7686631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury.
    Mulligan MS; Vaporciyan AA; Warner RL; Jones ML; Foreman KE; Miyasaka M; Todd RF; Ward PA
    J Immunol; 1995 Feb; 154(3):1350-63. PubMed ID: 7529801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine.
    Mulligan MS; Warren JS; Smith CW; Anderson DC; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 May; 148(10):3086-92. PubMed ID: 1374449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing patterns of P-selectin expression in lung injury.
    Bless NM; Tojo SJ; Kawarai H; Natsume Y; Lentsch AB; Padgaonkar VA; Czermak BJ; Schmal H; Friedl HP; Ward PA
    Am J Pathol; 1998 Oct; 153(4):1113-22. PubMed ID: 9777942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes.
    Mulligan MS; Wilson GP; Todd RF; Smith CW; Anderson DC; Varani J; Issekutz TB; Miyasaka M; Tamatani T
    J Immunol; 1993 Mar; 150(6):2407-17. PubMed ID: 7680691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of selectins in local and remote tissue injury following ischemia and reperfusion.
    Seekamp A; Till GO; Mulligan MS; Paulson JC; Anderson DC; Miyasaka M; Ward PA
    Am J Pathol; 1994 Mar; 144(3):592-8. PubMed ID: 7510457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo selectin-blocking activities of sulfated lipids and sulfated sialyl compounds.
    Mulligan MS; Warner RL; Lowe JB; Smith PL; Suzuki Y; Miyasaka M; Yamaguchi S; Ohta Y; Tsukada Y; Kiso M; Hasegawa A; Ward PA
    Int Immunol; 1998 May; 10(5):569-75. PubMed ID: 9645605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial targeting and enhanced antiinflammatory effects of complement inhibitors possessing sialyl Lewisx moieties.
    Mulligan MS; Warner RL; Rittershaus CW; Thomas LJ; Ryan US; Foreman KE; Crouch LD; Till GO; Ward PA
    J Immunol; 1999 Apr; 162(8):4952-9. PubMed ID: 10202042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats.
    Mulligan MS; Varani J; Dame MK; Lane CL; Smith CW; Anderson DC; Ward PA
    J Clin Invest; 1991 Oct; 88(4):1396-406. PubMed ID: 1717513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury.
    Mulligan MS; Jones ML; Vaporciyan AA; Howard MC; Ward PA
    J Immunol; 1993 Nov; 151(10):5666-74. PubMed ID: 7901280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice.
    Doerschuk CM; Quinlan WM; Doyle NA; Bullard DC; Vestweber D; Jones ML; Takei F; Ward PA; Beaudet AL
    J Immunol; 1996 Nov; 157(10):4609-14. PubMed ID: 8906840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-alpha and IL-1.
    Mulligan MS; Ward PA
    J Immunol; 1992 Jul; 149(1):331-9. PubMed ID: 1318904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic complement activation, lung injury, and products of lipid peroxidation.
    Ward PA; Till GO; Hatherill JR; Annesley TM; Kunkel RG
    J Clin Invest; 1985 Aug; 76(2):517-27. PubMed ID: 4031060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.